Cargando…

Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study

OBJECTIVES: The classification of seronegative arthritides can be challenging. Our aim was to examine the incidence of SpA diagnosis among patients initially diagnosed as seronegative RA. METHODS: Using nationwide Finnish registers from social insurance institutions, we identified all adult patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Paalanen, Kirsi, Puolakka, Kari, Nikiphorou, Elena, Hannonen, Pekka, Sokka, Tuulikki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121445/
https://www.ncbi.nlm.nih.gov/pubmed/33175968
http://dx.doi.org/10.1093/rheumatology/keaa623
_version_ 1783692354980413440
author Paalanen, Kirsi
Puolakka, Kari
Nikiphorou, Elena
Hannonen, Pekka
Sokka, Tuulikki
author_facet Paalanen, Kirsi
Puolakka, Kari
Nikiphorou, Elena
Hannonen, Pekka
Sokka, Tuulikki
author_sort Paalanen, Kirsi
collection PubMed
description OBJECTIVES: The classification of seronegative arthritides can be challenging. Our aim was to examine the incidence of SpA diagnosis among patients initially diagnosed as seronegative RA. METHODS: Using nationwide Finnish registers from social insurance institutions, we identified all adult patients who were diagnosed with incident seronegative RA [International Classification of Diseases (ICD)-10 code M06] from 1 January 2000 to 31 December 2014. The patients whose diagnoses subsequently changed to the ICD-10 codes of SpA (M07, M45, M46, K50 and K51) were identified in the national care register, until 31 December 2016. RESULTS: A total of 9784 adult seronegative RA patients were identified. Of these, 564 patients had their diagnosis subsequently changed to SpA: 275 (48.7%) patients with PsA, 245 (43.4%) patients with axial SpA and 44 (7.8%) patients with diagnoses related to IBD. The cumulative incidence of SpA diagnoses in 15 years was 10.4% (95% CI 8.9, 12.1) and 8.1% (95% CI 7.1, 9.3) in men and women, respectively. CONCLUSION: This study calls for vigilance in seronegative RA patients, especially those with more atypical presentations, since the diagnosis could change. The possibility of SpA diagnosis should be considered and specifically looked for, as this could impact on management and response to treatment.
format Online
Article
Text
id pubmed-8121445
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-81214452021-05-19 Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study Paalanen, Kirsi Puolakka, Kari Nikiphorou, Elena Hannonen, Pekka Sokka, Tuulikki Rheumatology (Oxford) Clinical Science OBJECTIVES: The classification of seronegative arthritides can be challenging. Our aim was to examine the incidence of SpA diagnosis among patients initially diagnosed as seronegative RA. METHODS: Using nationwide Finnish registers from social insurance institutions, we identified all adult patients who were diagnosed with incident seronegative RA [International Classification of Diseases (ICD)-10 code M06] from 1 January 2000 to 31 December 2014. The patients whose diagnoses subsequently changed to the ICD-10 codes of SpA (M07, M45, M46, K50 and K51) were identified in the national care register, until 31 December 2016. RESULTS: A total of 9784 adult seronegative RA patients were identified. Of these, 564 patients had their diagnosis subsequently changed to SpA: 275 (48.7%) patients with PsA, 245 (43.4%) patients with axial SpA and 44 (7.8%) patients with diagnoses related to IBD. The cumulative incidence of SpA diagnoses in 15 years was 10.4% (95% CI 8.9, 12.1) and 8.1% (95% CI 7.1, 9.3) in men and women, respectively. CONCLUSION: This study calls for vigilance in seronegative RA patients, especially those with more atypical presentations, since the diagnosis could change. The possibility of SpA diagnosis should be considered and specifically looked for, as this could impact on management and response to treatment. Oxford University Press 2020-11-11 /pmc/articles/PMC8121445/ /pubmed/33175968 http://dx.doi.org/10.1093/rheumatology/keaa623 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Science
Paalanen, Kirsi
Puolakka, Kari
Nikiphorou, Elena
Hannonen, Pekka
Sokka, Tuulikki
Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study
title Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study
title_full Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study
title_fullStr Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study
title_full_unstemmed Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study
title_short Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study
title_sort is seronegative rheumatoid arthritis true rheumatoid arthritis? a nationwide cohort study
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121445/
https://www.ncbi.nlm.nih.gov/pubmed/33175968
http://dx.doi.org/10.1093/rheumatology/keaa623
work_keys_str_mv AT paalanenkirsi isseronegativerheumatoidarthritistruerheumatoidarthritisanationwidecohortstudy
AT puolakkakari isseronegativerheumatoidarthritistruerheumatoidarthritisanationwidecohortstudy
AT nikiphorouelena isseronegativerheumatoidarthritistruerheumatoidarthritisanationwidecohortstudy
AT hannonenpekka isseronegativerheumatoidarthritistruerheumatoidarthritisanationwidecohortstudy
AT sokkatuulikki isseronegativerheumatoidarthritistruerheumatoidarthritisanationwidecohortstudy